Rachael A. Vaubel - Concepedia

Author

Rachael A. Vaubel

Mayo Clinic ORCID

Also Known As

R A Vaubel, R. Vaubel, Rachael A Vaubel, Rachael A. Vaubel, Rachael Ann Vaubel, Rachael Vaubel, Rachel A Vaubel

171

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Florida Mayo Clinic in Arizona University of Minnesota Harvard University

About

Rachael A. Vaubel is an author at Mayo Clinic specializing in medicine, genetics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	758
2	Molecular Genetics	2	2	123
3	Natural Sciences	1	1	50
4	Biochemistry	1	1	50
5	Molecular Biology	1	1	50

Rachael A. Vaubel

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy Iacopo Olivotto, Francesca Girolami, Michael J. Ackerman, Mayo Clinic Proceedings Cardiac MuscleCardiomyopathyHeart FailureStructural Heart DiseaseGenetics	2008	325
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy Iacopo Olivotto, Francesca Girolami, Michael J. Ackerman, Mayo Clinic Proceedings Cardiac MuscleCardiomyopathyHeart FailureStructural Heart DiseaseGenetics	2008	296
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma Rachael A. Vaubel, Shulan Tian, Dioval Remonde, Clinical Cancer Research	2019	223
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas Ganesh M. Shankar, Malak Abedalthagafi, Rachael A. Vaubel, Neuro-Oncology	2016	181
Molecular profiling of long-term IDH-wildtype glioblastoma survivors Danielle M. Burgenske, Jie Yang, Paul A. Decker, Neuro-Oncology	2019	80
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma Bianca M. Marin, Kendra A. Porath, Sonia Jain, Neuro-Oncology	2021	76
Recurrent copy number alterations in low‐grade and anaplastic pleomorphic xanthoastrocytoma with and without <i>BRAF</i> V600E mutation Rachael A. Vaubel, Alissa Caron, Seiji Yamada, Brain Pathology OncologyAnaplastic Pleomorphic XanthoastrocytomaBraf MutationTumor HeterogeneityPleomorphic Xanthoastrocytoma	2017	73
Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it? Rachael A. Vaubel, Valentina Zschernack, Quynh T. Tran, Brain Pathology	2020	64
Mutations in the Dimer Interface of Dihydrolipoamide Dehydrogenase Promote Site-specific Oxidative Damages in Yeast and Human Cells Rachael A. Vaubel, Pierre Rustin, Grazia Isaya Journal of Biological Chemistry Molecular BiologyMolecular GeneticsRedox BiologyDimer Interface MutationsOxidative Stress	2011	50
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier Minjee Kim, J. Daniel, David Calligaris, Molecular Cancer Therapeutics	2018	40

Page 1